Clinical trial
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From…
NCT00311311 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00311311 |
|---|---|
| Title | Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients |
| Official title | A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Kidney Failure |
| Intervention type | Drug |
| Interventions | tacrolimus, mycophenolate mofetil, prednisone, sirolimus |
| Enrollment | 72 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Jan 1, 2012 |
| First posted | Apr 5, 2006 |
| Last update posted | Sep 23, 2013 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: